These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2455590)

  • 1. Analysis of the levels of CA125, carcinoembryonic antigen, and CA19-9 in the cervical mucus for a detection of cervical adenocarcinoma.
    Fujii S; Konishi I; Nanbu Y; Nonogaki H; Kobayashi F; Sagawa N; Mori T; Endo K
    Cancer; 1988 Aug; 62(3):541-7. PubMed ID: 2455590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the levels of CA125, CA19-9, and CEA in the cervical mucus helps a diagnosis of cervical adenocarcinomas].
    Fujii S; Konishi I; Nanbu Y; Sagawa N; Nonogaki H; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2193-4. PubMed ID: 3480920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of the levels of CA125, CEA and CA19-9 in the cervical mucus samples obtained at various phases of the menstrual cycle and with inflammatory diseases of the uterine cervix].
    Nanbu Y; Fujii S; Konishi I; Nonogaki H; Kobayashi F; Sagawa N; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Oct; 40(10):1519-24. PubMed ID: 3225482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading.
    Neunteufel W; Bieglmayer C; Breitenecker G
    Arch Gynecol Obstet; 1988; 244(1):47-52. PubMed ID: 2853610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histochemical analysis of uterine cervical adenocarcinoma with reference to mucosubstances and distribution of CEA, CA125 and CA19-9].
    Maruyama C; Yamamichi N; Konishi F
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):429-36. PubMed ID: 3163714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
    Steinberg WM; Gelfand R; Anderson KK; Glenn J; Kurtzman SH; Sindelar WF; Toskes PP
    Gastroenterology; 1986 Feb; 90(2):343-9. PubMed ID: 2416628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen.
    Matsuoka Y; Endo K; Kawamura Y; Yoshida T; Saga T; Watanabe Y; Koizumi M; Nakashima T; Konishi J; Yamaguchi N
    Cancer; 1990 Feb; 65(3):506-10. PubMed ID: 2297641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
    Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
    JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical carcinoma: a comparison of four potential biochemical tumor markers.
    Dodd JK; Henry RJ; Tyler JP; Houghton CR
    Gynecol Oncol; 1989 Feb; 32(2):248-52. PubMed ID: 2910788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix.
    Kudo R; Sasano H; Koizumi M; Orenstein JM; Silverberg SG
    Int J Gynecol Pathol; 1990; 9(4):325-36. PubMed ID: 1700970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
    Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of CEA, CA19-9, and DF3 in esophageal carcinoma limited to the submucosal layer.
    Ikeda Y; Kuwano H; Ikebe M; Baba K; Toh Y; Adachi Y; Sugimachi K
    J Surg Oncol; 1994 May; 56(1):7-12. PubMed ID: 8176946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
    Duk JM; De Bruijn HW; Groenier KH; Fleuren GJ; Aalders JG
    Cancer; 1990 Apr; 65(8):1830-7. PubMed ID: 2317761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas.
    Maes G; Fleuren GJ; Bara J; Nap M
    Int J Gynecol Pathol; 1988; 7(2):112-22. PubMed ID: 3294194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
    Brown RW; Campagna LB; Dunn JK; Cagle PT
    Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.
    Aalders JG; de Bruijn HW; Oosterhuis JW; Duk JM
    Gynecol Oncol; 1990 Jan; 36(1):110-2. PubMed ID: 2295441
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
    Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
    Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.